<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>6(1)</volume><submitter>Lingani M</submitter><pubmed_abstract>&lt;h4>Background and aim&lt;/h4>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) particularly the variants of concern coinfections with influenza is a public health concern in Africa. We aimed to characterize the SARS-CoV-2 variants and determine the rate of coinfections with influenza in Burkina Faso.&lt;h4>Methods&lt;/h4>COVID-19 surveillance study was conducted between August 2021 and January 2022 using reverse transcription polymerase chain reaction (RT-PCR). Positive specimens were further screened for SARS-CoV-2 variants using the multiple variants real-time PCR kits. In addition, influenza virus strains were detected by RT-PCR in SARS-CoV-2 positive specimens using the CDC primers, probes, and protocols.&lt;h4>Results&lt;/h4>Of 324 specimens assessed, the Omicron and Delta variants of SA</pubmed_abstract><journal>Health science reports</journal><pagination>e1041</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9811340</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Coinfections with SARS-CoV-2 variants and influenza virus during the 2019 Coronavirus disease pandemic in Burkina Faso: A surveillance study.</pubmed_title><pmcid>PMC9811340</pmcid><pubmed_authors>Tialla D</pubmed_authors><pubmed_authors>Tao M</pubmed_authors><pubmed_authors>Lingani M</pubmed_authors><pubmed_authors>Gampini S</pubmed_authors><pubmed_authors>Cisse A</pubmed_authors><pubmed_authors>Ilboudo AK</pubmed_authors><pubmed_authors>Tarnagda G</pubmed_authors><pubmed_authors>Sawadogo C</pubmed_authors><pubmed_authors>Diagbouga S</pubmed_authors><pubmed_authors>Tarnagda Z</pubmed_authors><pubmed_authors>Savadogo M</pubmed_authors><pubmed_authors>Bamba S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Coinfections with SARS-CoV-2 variants and influenza virus during the 2019 Coronavirus disease pandemic in Burkina Faso: A surveillance study.</name><description>&lt;h4>Background and aim&lt;/h4>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) particularly the variants of concern coinfections with influenza is a public health concern in Africa. We aimed to characterize the SARS-CoV-2 variants and determine the rate of coinfections with influenza in Burkina Faso.&lt;h4>Methods&lt;/h4>COVID-19 surveillance study was conducted between August 2021 and January 2022 using reverse transcription polymerase chain reaction (RT-PCR). Positive specimens were further screened for SARS-CoV-2 variants using the multiple variants real-time PCR kits. In addition, influenza virus strains were detected by RT-PCR in SARS-CoV-2 positive specimens using the CDC primers, probes, and protocols.&lt;h4>Results&lt;/h4>Of 324 specimens assessed, the Omicron and Delta variants of SA</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Jan</publication><modification>2026-03-17T16:02:34.057Z</modification><creation>2025-04-04T12:37:35.855Z</creation></dates><accession>S-EPMC9811340</accession><cross_references><pubmed>36620510</pubmed><doi>10.1002/hsr2.1041</doi></cross_references></HashMap>